WAYSTAR HOLDING CORP (WAY) Stock Fundamental Analysis
USA - NASDAQ:WAY - US9467841055 - Common Stock
38.64 USD
+0.43 (+1.13%)
39 USD
+0.36 (+0.93%)
WAY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. Both the profitability and the financial health of WAY get a neutral evaluation. Nothing too spectacular is happening here. WAY is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year WAY was profitable.
In the past year WAY had a positive cash flow from operations.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.84%, WAY belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
WAY has a better Return On Equity (2.71%) than 88.57% of its industry peers.
WAY has a Return On Invested Capital of 3.67%. This is in the better half of the industry: WAY outperforms 80.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for WAY is below the industry average of 6.80%.
The 3 year average ROIC (2.09%) for WAY is below the current ROIC(3.67%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 2.71% | ||
| ROIC | 3.67% |
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 8.50%, WAY belongs to the top of the industry, outperforming 94.29% of the companies in the same industry.
Looking at the Operating Margin, with a value of 20.80%, WAY belongs to the top of the industry, outperforming 94.29% of the companies in the same industry.
In the last couple of years the Operating Margin of WAY has grown nicely.
With a decent Gross Margin value of 67.32%, WAY is doing good in the industry, outperforming 65.71% of the companies in the same industry.
In the last couple of years the Gross Margin of WAY has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.8% | ||
| PM (TTM) | 8.5% | ||
| GM | 67.32% |
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WAY is destroying value.
The number of shares outstanding for WAY has been increased compared to 1 year ago.
WAY has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.10 indicates that WAY is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.10, WAY is doing good in the industry, outperforming 68.57% of the companies in the same industry.
The Debt to FCF ratio of WAY is 4.45, which is a neutral value as it means it would take WAY, 4.45 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 4.45, WAY perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
WAY has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.39, WAY is doing worse than 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.45 | ||
| Altman-Z | 3.1 |
ROIC/WACC0.39
WACC9.46%
2.3 Liquidity
A Current Ratio of 3.43 indicates that WAY has no problem at all paying its short term obligations.
WAY's Current ratio of 3.43 is fine compared to the rest of the industry. WAY outperforms 80.00% of its industry peers.
A Quick Ratio of 3.43 indicates that WAY has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.43, WAY is doing good in the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.43 | ||
| Quick Ratio | 3.43 |
3. Growth
3.1 Past
WAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 199.63%, which is quite impressive.
The Revenue has grown by 17.14% in the past year. This is quite good.
Measured over the past years, WAY shows a quite strong growth in Revenue. The Revenue has been growing by 17.71% on average per year.
EPS 1Y (TTM)199.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)17.14%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%15.4%
3.2 Future
Based on estimates for the next years, WAY will show a very strong growth in Earnings Per Share. The EPS will grow by 78.53% on average per year.
Based on estimates for the next years, WAY will show a quite strong growth in Revenue. The Revenue will grow by 11.06% on average per year.
EPS Next Y342.82%
EPS Next 2Y123.19%
EPS Next 3Y78.53%
EPS Next 5YN/A
Revenue Next Year11.58%
Revenue Next 2Y10.98%
Revenue Next 3Y11.06%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 34.81, which means the current valuation is very expensive for WAY.
Based on the Price/Earnings ratio, WAY is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
WAY is valuated rather expensively when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 24.46, WAY is valued on the expensive side.
Based on the Price/Forward Earnings ratio, WAY is valued a bit cheaper than 80.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of WAY to the average of the S&P500 Index (23.32), we can say WAY is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.81 | ||
| Fwd PE | 24.46 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WAY indicates a somewhat cheap valuation: WAY is cheaper than 77.14% of the companies listed in the same industry.
WAY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. WAY is cheaper than 82.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.17 | ||
| EV/EBITDA | 20.2 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of WAY may justify a higher PE ratio.
WAY's earnings are expected to grow with 78.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y123.19%
EPS Next 3Y78.53%
5. Dividend
5.1 Amount
WAY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
38.64
+0.43 (+1.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners69.9%
Inst Owner Change5.66%
Ins Owners1.26%
Ins Owner Change5.79%
Market Cap6.73B
Analysts86
Price Target50.64 (31.06%)
Short Float %4.47%
Short Ratio2
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.52%
Min EPS beat(2)-1.27%
Max EPS beat(2)6.31%
EPS beat(4)3
Avg EPS beat(4)34.74%
Min EPS beat(4)-1.27%
Max EPS beat(4)103.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.16%
Min Revenue beat(2)2.36%
Max Revenue beat(2)3.95%
Revenue beat(4)4
Avg Revenue beat(4)4.17%
Min Revenue beat(4)2.36%
Max Revenue beat(4)6.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.21%
PT rev (3m)2.36%
EPS NQ rev (1m)-0.07%
EPS NQ rev (3m)5.08%
EPS NY rev (1m)0.21%
EPS NY rev (3m)4.64%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)0.99%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)2.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.81 | ||
| Fwd PE | 24.46 | ||
| P/S | 6.66 | ||
| P/FCF | 24.17 | ||
| P/OCF | 22.1 | ||
| P/B | 2.12 | ||
| P/tB | N/A | ||
| EV/EBITDA | 20.2 |
EPS(TTM)1.11
EY2.87%
EPS(NY)1.58
Fwd EY4.09%
FCF(TTM)1.6
FCFY4.14%
OCF(TTM)1.75
OCFY4.52%
SpS5.8
BVpS18.21
TBVpS-4.76
PEG (NY)0.1
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 2.71% | ||
| ROCE | 4.65% | ||
| ROIC | 3.67% | ||
| ROICexc | 3.97% | ||
| ROICexgc | 91.57% | ||
| OM | 20.8% | ||
| PM (TTM) | 8.5% | ||
| GM | 67.32% | ||
| FCFM | 27.55% |
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
ROICexc(3y)2.13%
ROICexc(5y)N/A
ROICexgc(3y)47.51%
ROICexgc(5y)N/A
ROCE(3y)2.64%
ROCE(5y)N/A
ROICexcg growth 3Y7.56%
ROICexcg growth 5YN/A
ROICexc growth 3Y30.65%
ROICexc growth 5YN/A
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
F-Score8
Asset Turnover0.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.45 | ||
| Debt/EBITDA | 3.27 | ||
| Cap/Depr | 15.78% | ||
| Cap/Sales | 2.57% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.15% | ||
| Profit Quality | 324.12% | ||
| Current Ratio | 3.43 | ||
| Quick Ratio | 3.43 | ||
| Altman-Z | 3.1 |
F-Score8
WACC9.46%
ROIC/WACC0.39
Cap/Depr(3y)12.11%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)199.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next Y342.82%
EPS Next 2Y123.19%
EPS Next 3Y78.53%
EPS Next 5YN/A
Revenue 1Y (TTM)17.14%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%15.4%
Revenue Next Year11.58%
Revenue Next 2Y10.98%
Revenue Next 3Y11.06%
Revenue Next 5YN/A
EBIT growth 1Y85.59%
EBIT growth 3Y27.06%
EBIT growth 5YN/A
EBIT Next Year134.75%
EBIT Next 3Y42.44%
EBIT Next 5YN/A
FCF growth 1Y375.9%
FCF growth 3Y15.76%
FCF growth 5YN/A
OCF growth 1Y229.9%
OCF growth 3Y16.85%
OCF growth 5YN/A